Signal Genetics Adds Precision Therapeutics to Suit
February 25, 2011
Signal Genetics Adds Precision Therapeutics to Suit
Signal filed its suit against Med BioGene earlier this month alleging a breach of agreement, violation of a confidentiality agreement, and misuse of proprietary information, among other charges.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.